BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33051879)

  • 1. Yeo and Darras: Extraneuronal Phenotypes of Spinal Muscular Atrophy.
    Yeo CJJ; Darras BT
    Ann Neurol; 2021 Jan; 89(1):24-26. PubMed ID: 33051879
    [No Abstract]   [Full Text] [Related]  

  • 2. Spinal muscular atrophies.
    Lancet; 1990 Aug; 336(8710):280-1. PubMed ID: 1973974
    [No Abstract]   [Full Text] [Related]  

  • 3. The genetics of the spinal muscular atrophies.
    Baraitser M
    Prog Clin Biol Res; 1989; 306():75-84. PubMed ID: 2662214
    [No Abstract]   [Full Text] [Related]  

  • 4. SMN gene deletions in adult-onset spinal muscular atrophy.
    Clermont O; Burlet P; Lefebvre S; Bürglen L; Munnich A; Melki J
    Lancet; 1995 Dec 23-30; 346(8991-8992):1712-3. PubMed ID: 8551862
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy.
    Brahe C; Servidei S; Zappata S; Ricci E; Tonali P; Neri G
    Lancet; 1995 Sep; 346(8977):741-2. PubMed ID: 7658877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked infantile spinal muscular atrophy.
    Greenberg F; Fenolio KR; Hejtmancik JF; Armstrong D; Willis JK; Shapira E; Huntington HW; Haun RL
    Am J Dis Child; 1988 Feb; 142(2):217-9. PubMed ID: 3341327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal Muscular Atrophy Type 1 With Exon 8 Deletion and Bilateral Optic Atrophy.
    Behera B; Kumar A
    Indian Pediatr; 2020 Dec; 57(12):1191. PubMed ID: 33318336
    [No Abstract]   [Full Text] [Related]  

  • 8. Coexistence of Spinal Muscular Atrophy Type 1 and Factor X1 Deficiency.
    Kaya G; Bahadir A; Acar Arslan E
    J Pediatr Hematol Oncol; 2022 Apr; 44(3):115-116. PubMed ID: 33560085
    [No Abstract]   [Full Text] [Related]  

  • 9. Controversy over Werdnig-Hoffmann disease and multiple system atrophy.
    Chou SM
    Curr Opin Neurol; 1993 Dec; 6(6):861-4. PubMed ID: 8293160
    [No Abstract]   [Full Text] [Related]  

  • 10. [The spectrum of spinal muscular atrophies: a population study].
    Rudenskaia GE; Mamedova RA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(8):22-5. PubMed ID: 9343477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective.
    Oskoui M; Gonorazky H; McMillan HJ; Dowling JJ; Amin R; Gagnon C; Selby K
    Can J Neurol Sci; 2022 May; 49(3):398-401. PubMed ID: 34082851
    [No Abstract]   [Full Text] [Related]  

  • 12. Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators.
    Melki J; Sheth P; Abdelhak S; Burlet P; Bachelot MF; Lathrop MG; Frezal J; Munnich A
    Lancet; 1990 Aug; 336(8710):271-3. PubMed ID: 1973971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of full-length mRNA for cBCD541 does not correlate with spinal muscular atrophy phenotype severity.
    Nishio H; Ishikawa Y; Lee MJ; Fujii M; Kanda F; Jinnai K; Takahashi K; Takeshima Y; Wada H; Takada S; Nakamura H; Matsuo M; Sumino K
    Neurology; 1997 May; 48(5):1266-70. PubMed ID: 9153454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary motor neuronopathies.
    Zamba-Papanicolaou E; Christodoulou K; Christodoulou C; Kyriakidesl T; Middleton LT
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 1):1220-4. PubMed ID: 12690745
    [No Abstract]   [Full Text] [Related]  

  • 15. Werdnig-Hoffmann disease and chronic distal spinal muscular atrophy with apparent autosomal dominant inheritance.
    Boylan KB; Cornblath DR
    Ann Neurol; 1992 Sep; 32(3):404-7. PubMed ID: 1416812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene replacement therapy for spinal muscular atrophy unmasking occult hepatitis C in a pediatric patient.
    Lakhotia A; Turek G; Green J; Khan M
    Muscle Nerve; 2022 Jan; 65(1):E2-E3. PubMed ID: 34644404
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and mutational characteristics of spinal muscular atrophy with respiratory distress type 1 in The Netherlands.
    Stalpers XL; Verrips A; Poll-The BT; Cobben JM; Snoeck IN; de Coo IF; Brooks A; Bulk S; Gooskens R; Fock A; Verschuuren-Bemelmans C; Sinke RJ; de Visser M; Lemmink HH
    Neuromuscul Disord; 2013 Jun; 23(6):461-8. PubMed ID: 23566544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo and inherited deletions of the 5q13 region in spinal muscular atrophies.
    Melki J; Lefebvre S; Burglen L; Burlet P; Clermont O; Millasseau P; Reboullet S; Bénichou B; Zeviani M; Le Paslier D
    Science; 1994 Jun; 264(5164):1474-7. PubMed ID: 7910982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurogenic arthrogryposis and the power of phenotyping.
    Rossor AM; Reilly MM
    Neuromuscul Disord; 2021 Oct; 31(10):1062-1069. PubMed ID: 34736627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
    J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.